tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Oncotelic Therapeutics (OTLC)
OTHER OTC:OTLC
US Market
OTLC
Oncotelic Therapeutics
RESEARCH TOOLSreports
Advertisement

Oncotelic Therapeutics (OTLC) Stock News & Sentiment

Compare
83 Followers
Oncotelic Therapeutics Partners with Jefferson and Valor
Premium
Company Announcements
Oncotelic Therapeutics Partners with Jefferson and Valor
2M ago
8K
OTLC
Oncotelic Therapeutics Signs Equity Purchase Agreement
Premium
Company Announcements
Oncotelic Therapeutics Signs Equity Purchase Agreement
2M ago
8K
OTLC
Oncotelic Therapeutics Delays Yearly Report Filing
Premium
Company Announcements
Oncotelic Therapeutics Delays Yearly Report Filing
6M ago
OTLC

OTLC News on the Web

Sapu Nano's Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
InvestorsHub
Neutral
Advancing Cancer Research Brings New Hope for Patients Worldwide
InvestorsHub
Neutral
Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth
InvestorsHub
Neutral
Oncotelic Therapeutics Highlights 2 Years of Clinical and Regulatory Advancements Across Late-Stage Pipeline
InvestorsHub
Neutral
Dr. Vuong Trieu, Developer of Novel Oncology and Immunotherapy Assets, Leads Oncotelic Therapeutics' Commitment to Innovation, Life-Saving Therapies Dr. Trieu's prolific career includes multibillion-dollar drug discoveries targeting cancers of the breast,
InvestorsHub
Bullish
Oncotelic Therapeutics Showcases Robust Pipeline and Founder's Broad Intellectual Property Contributions to Biopharma Industry
InvestorsHub
Neutral
Oncotelic CEO Vuong Trieu to Present Innovative "Deciparticles" Platform at ...
GuruFocus News
Neutral
Oncotelic Accesses Rapid IND Development Platform through Partnership with Medicilon
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
OTLC
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OTLC’s Media Buzz Sentiment?
Currently, no data Available
What is OTLC’s weekly average amount of articles?
Currently, no data Available
What is OTLC’s News Sentiment?
59% of articles about OTLC were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    ARQTArcutis Biotherapeutics
    COLLCollegium Pharmaceutical
    PODDInsulet
    PXSProvexis
    PRMProteome Sciences
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing